The last minute, two-year suspension of the device excise tax that went through last month wasn't exactly what Mark Leahey, president and CEO of the Medical Device Manufacturers Association, had in mind at the start of 2017 when all cylinders were firing at MDMA and aligned groups for a permanent repeal. But, "with the political environment we're in right now," companies are satisfied that the tax was temporarily turned off before the first payments were due Jan. 29, he said in an interview.
Podcast: DC Reflections – Mark Leahey On MDMA's 2018 Priorities And The Medtech Landscape
In an interview with Medtech Insight, MDMA CEO Mark Leahey talked about the industry group's ongoing efforts to fully repeal the medical device tax, reimbursement challenges, cybersecurity and more. Check out the summary, the podcast and the transcript.
